“…Regionally-derived endogenous iNSPCs were isolated from ischemic areas of mice after MCAO and maintained in Dulbecco’s modified Eagle’s medium/F12 (Thermo Fisher Scientific, Waltham, MA, USA) containing 20 ng/mL basic fibroblast growth factor (bFGF; Peprotech, Rocky Hill, NJ, USA), 20 ng/mL epidermal growth factor (EGF; Peprotech), 1% N2 (Thermo Fisher Scientific), and 2% fetal bovine serum (FBS), as previously described [ 11 ]. Commercially available mouse brain MGs/MΦs (#SCC134; EMD Millipore, Temecula, CA, USA), ACs (#M1800; ScienCell Research Laboratories, Carlsbad, CA, USA), PCs (#M1200; ScienCell Research Laboratories), and ECs (CRL-2299; ATCC, Manassas, VA, USA) were maintained in appropriate media in accordance with the manufacturer’s protocols, as described [ 6 ]. In some experiments, iNSPCs transfected with GFP-expressing lentivirus vectors and MGs/MΦs, ACs, ECs, and PCs transfected with mCherry-expressing lentivirus vectors were used [ 6 , 10 , 12 ].…”